Clinical Cyber Dispatch Methodology

Effective date: May 13, 2026

Source list

Primary sources include vendor advisories, NVD, CISA KEV, HHS HC3, OCR, FDA, state regulator materials, official company disclosures, and other authoritative public sources. Secondary reporting may be used for context but should not create unsupported claims.

Selection criteria

Stories should help readers decide what to investigate, who needs to act, or how a development could affect care, patient data or service availability. Items that do not change a decision stay in the detail sections or are excluded.

Healthcare Incident Watch

Incident Watch separates verified material items from secondary-source awareness. Verified material items require an official company notice, regulator posting, OCR/HHS breach portal entry, state attorney general notice, court or settlement document, or similarly authoritative source. Secondary reporting can appear for awareness, but it should not trigger breach notification, OCR reporting, or incident-response escalation unless local scope or evidence exists.

A new article does not make an old incident new. Coverage of older events needs a verified update, such as a regulator posting, official notice, changed affected count, settlement or lawsuit.

How we assess healthcare relevance

We consider whether a development could affect clinical workflows, patient information, medical devices or operational technology, shared suppliers, or access to important systems. These factors help explain why a story matters to healthcare. They do not establish whether your organization is affected or replace technical severity ratings. Check the affected products, versions and dependencies against your own environment before acting.

Check exploitation evidence, KEV status and vendor fixed releases separately.

Confidence model

Source confidence combines evidence type, source quality, corroboration, and specificity. Vendor-confirmed and government-catalog evidence is stronger than analyst inference. Analyst judgment is labeled when a healthcare operational conclusion is inferred from deployment patterns rather than directly stated by a source.

KEV and exploitation-source explanation

CISA KEV, vendor statements, NVD records, credible exploitation catalogs, and public exploit reporting are treated separately. A KEV entry or public exploit can change operational priority, but it does not by itself prove healthcare targeting, clinical compromise, PHI exposure, or breach status.

Clinical and privacy limits

A CVE, KEV listing, or vulnerability disclosure is not a clinical compromise or HIPAA breach finding. Direct clinical impact requires evidence that the affected system is a clinical system, medical device, clinical communication platform, imaging system, medication system, EHR component, or confirmed patient-care dependency.

Medical device and OT coverage limitations

Medical-device and OT coverage is limited to public FDA communications, vendor advisories, CISA ICS advisories, HHS HC3 materials, and clearly bounded telemetry. A single sensor, lab signal, or generic internet scan is not treated as sector-level healthcare OT/IoMT intelligence unless corroborated by material healthcare evidence.

AI-assisted drafting disclosure

Clinical Cyber Dispatch may use AI-assisted drafting, summarization, classification, and formatting. Human review and automated QA gates are used to constrain clinical, privacy, regulatory, attribution, and exploitation claims to evidence-supported language.

Correction process

If a reader identifies an error, stale source, broken link, or unsupported claim, contact ceo.clinicalcyber@proton.me. Corrections may be applied to the current issue, noted in a later issue, or used to update methodology and QA gates.

Limitations

The publication is informational only and is not legal, regulatory, compliance, medical, or incident-response advice. Readers should verify CVE and remediation data against vendor advisories and internal asset data before making operational decisions.